The last decade has ushered in exploding prescription drug costs with the proliferation of specialty drugs. My colleague, Craig Hasday, blogged about controlling these health plan costs last week. And although many of those drugs placed a major dent in our client’s healthcare plans, the next batch of specialty meds – gene therapy drugs –... [Read More]